370 related articles for article (PubMed ID: 15297047)
1. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.
Fan J; Liang X; Horton MS; Perry HC; Citron MP; Heidecker GJ; Fu TM; Joyce J; Przysiecki CT; Keller PM; Garsky VM; Ionescu R; Rippeon Y; Shi L; Chastain MA; Condra JH; Davies ME; Liao J; Emini EA; Shiver JW
Vaccine; 2004 Aug; 22(23-24):2993-3003. PubMed ID: 15297047
[TBL] [Abstract][Full Text] [Related]
2. Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys.
Fu TM; Grimm KM; Citron MP; Freed DC; Fan J; Keller PM; Shiver JW; Liang X; Joyce JG
Vaccine; 2009 Feb; 27(9):1440-7. PubMed ID: 19146898
[TBL] [Abstract][Full Text] [Related]
3. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
[TBL] [Abstract][Full Text] [Related]
4. Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus.
Lalor PA; Webby RJ; Morrow J; Rusalov D; Kaslow DC; Rolland A; Smith LR
J Infect Dis; 2008 Jun; 197(12):1643-52. PubMed ID: 18513153
[TBL] [Abstract][Full Text] [Related]
5. A universal influenza A vaccine based on the extracellular domain of the M2 protein.
Neirynck S; Deroo T; Saelens X; Vanlandschoot P; Jou WM; Fiers W
Nat Med; 1999 Oct; 5(10):1157-63. PubMed ID: 10502819
[TBL] [Abstract][Full Text] [Related]
6. Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus.
Fu TM; Freed DC; Horton MS; Fan J; Citron MP; Joyce JG; Garsky VM; Casimiro DR; Zhao Q; Shiver JW; Liang X
Virology; 2009 Mar; 385(1):218-26. PubMed ID: 19070878
[TBL] [Abstract][Full Text] [Related]
7. Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.
Price GE; Soboleski MR; Lo CY; Misplon JA; Pappas C; Houser KV; Tumpey TM; Epstein SL
Vaccine; 2009 Nov; 27(47):6512-21. PubMed ID: 19729082
[TBL] [Abstract][Full Text] [Related]
8. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.
Bianchi E; Liang X; Ingallinella P; Finotto M; Chastain MA; Fan J; Fu TM; Song HC; Horton MS; Freed DC; Manger W; Wen E; Shi L; Ionescu R; Price C; Wenger M; Emini EA; Cortese R; Ciliberto G; Shiver JW; Pessi A
J Virol; 2005 Jun; 79(12):7380-8. PubMed ID: 15919893
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets.
Song MS; Oh TK; Pascua PN; Moon HJ; Lee JH; Baek YH; Woo KJ; Yoon Y; Sung MH; Poo H; Kim CJ; Choi YK
Vaccine; 2009 May; 27(24):3145-52. PubMed ID: 19446184
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.
Liu W; Zou P; Chen YH
Immunol Lett; 2004 May; 93(2-3):131-6. PubMed ID: 15158608
[TBL] [Abstract][Full Text] [Related]
11. Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies.
Lo CY; Wu Z; Misplon JA; Price GE; Pappas C; Kong WP; Tumpey TM; Epstein SL
Vaccine; 2008 Apr; 26(17):2062-72. PubMed ID: 18378366
[TBL] [Abstract][Full Text] [Related]
12. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
13. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
[TBL] [Abstract][Full Text] [Related]
14. Genetic control of immune responses to influenza A matrix 2 protein (M2).
Misplon JA; Lo CY; Gabbard JD; Tompkins SM; Epstein SL
Vaccine; 2010 Aug; 28(36):5817-27. PubMed ID: 20600476
[TBL] [Abstract][Full Text] [Related]
15. Induction of protection against divergent H5N1 influenza viruses using a recombinant fusion protein linking influenza M2e to Onchocerca volvulus activation associated protein-1 (ASP-1) adjuvant.
Zhao G; Du L; Xiao W; Sun S; Lin Y; Chen M; Kou Z; He Y; Lustigman S; Jiang S; Zheng BJ; Zhou Y
Vaccine; 2010 Oct; 28(44):7233-40. PubMed ID: 20732469
[TBL] [Abstract][Full Text] [Related]
16. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
[TBL] [Abstract][Full Text] [Related]
17. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.
Sandbulte MR; Jimenez GS; Boon AC; Smith LR; Treanor JJ; Webby RJ
PLoS Med; 2007 Feb; 4(2):e59. PubMed ID: 17298168
[TBL] [Abstract][Full Text] [Related]
18. The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection.
Zou P; Liu W; Chen YH
Int Immunopharmacol; 2005 Apr; 5(4):631-5. PubMed ID: 15710332
[TBL] [Abstract][Full Text] [Related]
19. Design and optimization of a multiplex anti-influenza peptide immunoassay.
Drummond JE; Shaw EE; Antonello JM; Green T; Page GJ; Motley CO; Wilson KA; Finnefrock AC; Liang X; Casimiro DR
J Immunol Methods; 2008 May; 334(1-2):11-20. PubMed ID: 18329663
[TBL] [Abstract][Full Text] [Related]
20. Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.
Haynes JR; Dokken L; Wiley JA; Cawthon AG; Bigger J; Harmsen AG; Richardson C
Vaccine; 2009 Jan; 27(4):530-41. PubMed ID: 19026705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
